ProQR Therapeutics N.V Live Stock Price Today, Share Analysis and Chart

Name: ProQR Therapeutics N.V: Is Infosys Ltd. worth buying?
Item: ProQR Therapeutics N.V
Rating: 2.22208325
Author: Trendlyne DVM scores

about

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The onl...

2.90 0.12 (4.32%)

33.79% Fall from 52W High

228.7K

XNAS Volume

XNAS 20 Oct, 2025 10:13 AM (EDT)

Board Meeting

The next board meeting for ProQR Therapeutics N.V is on 21 Oct 2025 for the purpose of ProQR Chardan’s 9th Annual Genetic Medicines Conference 2025 See details

Not Eligible

Expensive Valuation

13.8 / 100

Technically Bullish

75.1 / 100

1Yr Price target upside is 206%

8 analysts

ProQR Therapeutics NV Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..